Citation: Zhang Yaling, Ma Shasha, Li Xiabing, Hou Qiaoli, Lü Mengjiao, Hao Yunxia, Wang Wei, Li Baolin. Synthesis and Antiproliferative Activities of Novel Pyrrolotriazine Derivatives[J]. Chinese Journal of Organic Chemistry, ;2018, 38(12): 3270-3277. doi: 10.6023/cjoc201805005 shu

Synthesis and Antiproliferative Activities of Novel Pyrrolotriazine Derivatives

Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an 710062

Corresponding author: Li Xiabing, xiabingli@snnu.edu.cn Li Baolin, baolinli@snnu.edu.cn
Received Date: 2 May 2018
Revised Date: 18 June 2018
Available Online: 22 December 2018
Fund Project: the Fundamental Research Funds for the Central Universities GK201706005Project supported by the National Natural Science Foundation of China (No. 21272144) and the Fundamental Research Funds for the Central Universities (Nos. GK201603034, GK201706005, X2015YB06)the Fundamental Research Funds for the Central Universities X2015YB06the National Natural Science Foundation of China 21272144the Fundamental Research Funds for the Central Universities GK201603034

Figures(3)

In order to find novel antitumor agents with high efficiency and low toxicity, 11 novel pyrrolo[2, 1-f] [1, 2, 4]triazine derivatives were designed and synthesized through the introduction of varied structural moieties to the 4, 6-positions of pyrrolotriazine core. The antiproliferative activities of synthesized compounds were also evaluated against human tumor cells. Firstly, 2-amino-2-cyanoacetamide (1) was prepared from methyl cyanoacetate as a starting material through three step reactions of oximation, reduction and ammonolysis. Meanwhile, ethyl 2-acetyl-3-(dimethylamino)acrylate (2) was obtained from the reaction of ethyl acetoacetate with N, N-dimethylformamide dimethyl acetal. Then the cyclization reaction of 1 with 2 gave ethyl 5-cyano-4-methylpyrrole-3-carboxylate (4). Finally, pyrrolotriazine derivatives as target compounds were synthesized from 4 through the ammoniation, generating amidine, Dimroth rearrangement, and subsequent hydrolyzation and acylation. The antiproliferative activities of target compounds against human tumor cell lines were investigated by methyl thiazolyl tetrazolium (MTT) colorimetric assay. The results demonstrated that most synthesized compounds had obviously selective inhibitory effects against A431 cells with highly expressed wild type epidermal growth factor receptor (EGFR). Ethyl 4-(3-ethynylphenylamino)-5-methylpyrrolo[2, 1-f] [1, 2, 4]triazine-6-carboxylate (7c), 4-(3-chloro-4-(3-fluorobenzyloxy)phenyl-amino)-5-methylpyrrolo[2, 1-f] [1, 2, 4]triazine-6-carboxylic acid (8a) and 4-(3-ethynylphenylamino)-5-methylpyrrolo[2, 1-f]-[1, 2, 4]triazine-6-(N-(2-(methylsulfonyl)ethyl))carboxamide (9c) were the most potent agents with IC₅₀ values of 20.05, 21.98 and 23.87 μmol·L^-1 in the synthesized compounds, respectively. Preliminary structure-activity relationship analysis indicated that the introduction of 3-chloro-4-(3-fluorobenzyloxy)phenylamino and 3-ethynylphenylamino to 4-position of pyrrolotriazine-6-carboxylic acids or its esters can lead to enhance antiproliferative activities against A431 tumour cells.
- pyrrolotriazine,
- 4-arylaminopyrrolotriazine,
- Dimroth rearrangement,
- tumor,
- antiproliferative activity
1. [1]
  Bray, F.; Jemal, A.; Grey, N.; Ferlay, J.; Forman, D. Lancet Oncol. 2012, 13, 790. doi: 10.1016/S1470-2045(12)70211-5
2. [2]
  Siegel, R. L.; Miller, K. D.; Jemal, A. Ca-Cancer J. Clin. 2017, 67, 7. doi: 10.3322/caac.21387
3. [3]
  Anon, T. Cell 2017, 168, 545. doi: 10.1016/j.cell.2017.01.036
4. [4]
  Zhou, W.; Ercan, D.; Chen, L.; Yun, C. H.; Li, D.; Capelletti, M.; Cortot, A. B.; Chirieac, L.; Iacob, R. E.; Padera, R.; Engen, J. R.; Wong, K. K.; Eck, M. J.; Gray, N. S.; Janne, P. A. Nature 2009, 462, 1070. doi: 10.1038/nature08622
5. [5]
  Dhillon, S. Targeted Oncol. 2015, 10, 153. doi: 10.1007/s11523-015-0358-9
6. [6]
  Cohen, M. H.; Williams, G. A.; Sridhara, R.; Chen, G.; Pazdur, R. Oncologist 2003, 8, 303. doi: 10.1634/theoncologist.8-4-303
7. [7]
  Ryan, Q.; Ibrahim, A.; Cohen, M. H.; Johnson, J.; Ko, C. W.; Sridhara, R.; Justice, R.; Pazdur, R. Oncologist 2008, 13, 1114. doi: 10.1634/theoncologist.2008-0816
8. [8]
  Kuwano, M.; Sonoda, K.; Murakami, Y.; Watari, K.; Ono, M. Pharmacol. Therapeut. 2016, 161, 97. doi: 10.1016/j.pharmthera.2016.03.002
9. [9]
  Jia, Y.; Yun, C. H.; Park, E.; Ercan, D.; Manuia, M.; Juarez, J.; Xu, C.; Rhee, K.; Chen, T.; Zhang, H.; Palakurthi, S.; Jang, J.; Lelais, G.; Didonato, M.; Bursulaya, B.; Michellys, P. Y.; Epple, R.; Marsilje, T. H.; Mcneill, M.; Lu, W.; Harris, J.; Bender, S.; Wong, K. K.; Janne, P. A.; Eck, M. J. Nature 2016, 534, 129. doi: 10.1038/nature17960
10. [10]
  Chen, L.; Zhang, Y.; Liu, J.; Wang, W.; Li, X.; Zhao, L.; Wang, W.; Li, B. Eur. J. Med. Chem. 2017, 138, 689. doi: 10.1016/j.ejmech.2017.06.023
11. [11]
  Towles, J. K.; Clark, R. N.; Wahlin, M. D.; Uttamsingh, V.; Rettie, A. E.; Jackson, K. D. Drug Metab. Dispos. 2016, 44, 1584. doi: 10.1124/dmd.116.070839
12. [12]
  Dempke, W. C.; Zippel, R. Anticancer Res. 2010, 30, 4477.
13. [13]
  Chou, T.; Finn, R. S. Future Oncol. 2012, 8, 1083. doi: 10.2217/fon.12.104
14. [14]
  Finn, R. S.; Kang, Y. K.; Mulcahy, M.; Polite, B. N.; Lim, H. Y.; Walters, I.; Baudelet, C.; Manekas, D.; Park, J. W. Clin. Cancer Res. 2012, 18, 2090. doi: 10.1158/1078-0432.CCR-11-1991
15. [15]
  Wu, X.; Yang, M.; Shu, Q.; Zhu, C. WO 2013178021, 2013[Chem. Abstr. 2013, 187, 5272].
16. [16]
  Li, Q.; Lescrinier, E.; Groaz, E.; Persoons, L.; Daelemans, D.; Herdewijn, P.; De Jonghe, S. ChemMedChem 2018, 13, 97. doi: 10.1002/cmdc.v13.1
17. [17]
  Degorce, S. L.; Anjum, R.; Dillman, K. S.; Drew, L.; Groombridge, S. D.; Halsall, C. T.; Lenz, E. M.; Lindsay, N. A.; Mayo, M. F.; Pink, J. H.; Robb, G. R.; Scott, J. S.; Stokes, S.; Xue, Y. Bioorg. Med. Chem. 2018, 26, 913.
18. [18]
  Ma, S.-S.; Zhang, Y.-L.; Zhang, X.-Q.; Gu, H.-M.; Li, B.-L. Chem. Res. Appl. 2015, 27, 870 (in Chinese). doi: 10.3969/j.issn.1004-1656.2015.06.016
19. [19]
  Zhang, Y.; Chen, L.; Xu, H.; Li, X.; Zhao, L.; Wang, W.; Li, B.; Zhang, X. Eur. J. Med. Chem. 2018, 147, 77. doi: 10.1016/j.ejmech.2018.01.090
20. [20]
  Li, B.; Ma, S.; Li, J.; Wang, L.; Liu, J.; Chen, L. CN 104788460, 2015[Chem. Abstr. 2015, 119, 3561].
21. [21]
  Gavai, A. V.; Wen-Ching, H.; Ping, C.; Ruediger, E. H.; Harold, M.; Fink. B. E.; Norris, D. J. WO 2005065266, 2005[Chem. Abstr. 2005, 638, 632].
22. [22]
  Borzilleri, R. M.; Cai, Z. W.; Ellis, C.; Fargnoli, J.; Fura, A.; Gerhardt, T.; Goyal, B.; Hunt, J. T.; Mortillo, S.; Qian, L.; Tokarski, J.; Vyas, V.; Wautlet, B.; Zheng, X.; Bhide, R. S. Bioorg. Med. Chem. Lett. 2005, 15, 1429. doi: 10.1016/j.bmcl.2004.12.079
23. [23]
  Chandregowda, V.; Rao, G. V.; Reddy, G. C. Org. Process Res. Dev. 2007, 11, 813. doi: 10.1021/op700054p
24. [24]
  Zhan, D.; Li, S.; Zhao, H.; Lan, M. Chin. J. Org. Chem. 2011, 31, 207 (in Chinese).
25. [25]
  Wang, D.; Yu, J.; Li, W.; Cui, Q.; Feng, S. Chin. J. Org. Chem. 2012, 32, 1547 (in Chinese).
26. [26]
  Wong, R.; Turlova, E.; Feng, Z. P.; Rutka, J. T.; Sun, H. S. Oncotarget 2017, 8, 11239.
27. [27]
  Chen, W. L.; Turlova, E.; Sun, C. L.; Kim, J. S.; Huang, S.; Zhong, X.; Guan, Y. Y.; Wang, G. L.; Rutka, J. T.; Feng, Z. P.; Sun, H. S. Mar. Drugs 2015, 13, 2505. doi: 10.3390/md13042505
28. [28]
  Zhang, Y.; Zhang, Y.; Liu, J.; Chen, L.; Zhao, L.; Li, B.; Wang, W. Bioorg. Med. Chem. Lett. 2017, 27, 1584. doi: 10.1016/j.bmcl.2017.02.027
29. [29]
  Bhaskar, B. S.; Singh, S. G.; Neeraj, G.; Kumar, T. P.; Srinivasan, C. V.; Lalit, W. WO 2010140168, 2010[Chem. Abstr. 2010, 153, 0544].
30. [30]
  Wu, Z.; Wang, X.; Zhou, J. CN 1250773, 2000[Chem. Abstr. 2000, 862, 111].
31. [31]
  Ogan, M. D.; Tran, S. B.; Rinehart, J. K. J. Labelled Compd. Radiopharm. 2006, 49, 139. doi: 10.1002/(ISSN)1099-1344
32. [32]
  Cohnen, E.; Dewald, R. Synthesis 1987, 566.
33. [33]
  Zhang, Y.; Lü, M.; Zhang, Y.; Chen, L.; Wang, W.; Li, B. Chin. J. Org. Chem. 2017, 37, 1787 (in Chinese).
1. [1]
  Aiai WANG , Lu ZHAO , Yunfeng BAI , Feng FENG . Research progress of bimetallic organic framework in tumor diagnosis and treatment. Chinese Journal of Inorganic Chemistry, 2024, 40(10): 1825-1839. doi: 10.11862/CJIC.20240225
2. [2]
  Tingting XU , Wenjing ZHANG , Yongbo SONG . Research advances of atomic precision coinage metal nanoclusters in tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2275-2285. doi: 10.11862/CJIC.20240229
3. [3]
  Keliang Li , Guoqiang Dong , Shanchao Wu , Chunquan Sheng . Discovery of an activatable near-infrared fluorescent and theranostic PROTAC for tumor-targeted detecting and degrading of BRD4. Chinese Chemical Letters, 2025, 36(6): 110280-. doi: 10.1016/j.cclet.2024.110280
4. [4]
  Yang Liu , Minglu Li , Jianxun Ding , Xuesi Chen . Glycoengineering-assistant biomineralization for tumor blockade therapy. Chinese Chemical Letters, 2025, 36(5): 110146-. doi: 10.1016/j.cclet.2024.110146
5. [5]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
6. [6]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
7. [7]
  Hailang Deng , Abebe Reda Woldu , Abdul Qayum , Zanling Huang , Weiwei Zhu , Xiang Peng , Paul K. Chu , Liangsheng Hu . Killing two birds with one stone: Enhancing the photoelectrochemical water splitting activity and stability of BiVO₄ by Fe ions association. Chinese Chemical Letters, 2024, 35(12): 109892-. doi: 10.1016/j.cclet.2024.109892
8. [8]
  Xiaohong Wen , Mei Yang , Lie Li , Mingmin Huang , Wei Cui , Suping Li , Haiyan Chen , Chen Li , Qiuping Guo . Enzymatically controlled DNA tetrahedron nanoprobes for specific imaging of ATP in tumor. Chinese Chemical Letters, 2024, 35(8): 109291-. doi: 10.1016/j.cclet.2023.109291
9. [9]
  Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
10. [10]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
11. [11]
  Zhihui Zhang , Ru Sun , Chong Bian , Hongbo Wang , Zhen Zhao , Panpan Lv , Jianzhong Lu , Haixin Zhang , Hulie Zeng , Yuanyuan Chen , Zhijuan Cao . A dual-protease-triggered chemiluminescent probe for precise tumor imaging. Chinese Chemical Letters, 2025, 36(2): 109784-. doi: 10.1016/j.cclet.2024.109784
12. [12]
  Lei ZHANG , Cheng HE , Yang JIAO . An azo-based fluorescent probe for the detection of hypoxic tumor cells. Chinese Journal of Inorganic Chemistry, 2025, 41(6): 1162-1172. doi: 10.11862/CJIC.20250081
13. [13]
  Mengwei Ye , Qingqing Xu , Huanhuan Jian , Yiduo Ding , Wenpeng Zhao , Chenxiao Wang , Junya Lu , Shuaipeng Feng , Siling Wang , Qinfu Zhao . Recent trends of biodegradable mesoporous silica based nanoplatforms for enhanced tumor theranostics. Chinese Chemical Letters, 2025, 36(6): 110221-. doi: 10.1016/j.cclet.2024.110221
14. [14]
  Yi Cao , Xiaojiao Ge , Yuanyuan Wei , Lulu He , Aiguo Wu , Juan Li . Tumor microenvironment-activatable neuropeptide-drug conjugates enhanced tumor penetration and inhibition via multiple delivery pathways and calcium deposition. Chinese Chemical Letters, 2024, 35(4): 108672-. doi: 10.1016/j.cclet.2023.108672
15. [15]
  Ting Pan , Dinghu Zhang , Guomei You , Xiaoxia Wu , Chenguang Zhang , Xinyu Miao , Wenzhi Ren , Yiwei He , Lulu He , Yuanchuan Gong , Jie Lin , Aiguo Wu , Guoliang Shao . PD-L1 targeted iron oxide SERS bioprobe for accurately detecting circulating tumor cells and delineating tumor boundary. Chinese Chemical Letters, 2025, 36(1): 109857-. doi: 10.1016/j.cclet.2024.109857
16. [16]
  Honghao Sun , Huimin Zhao , Ronghui Yin , Chenxi Zhou , Ming Wu , Yueyang Deng , Zhanwei Zhou , Minjie Sun . Injectable hydrogel-based tumor vaccine with fibrotic tumor immune microenvironment remodeling to prevent breast cancer postoperative recurrence and metastases. Chinese Chemical Letters, 2025, 36(5): 110067-. doi: 10.1016/j.cclet.2024.110067
17. [17]
  Ying-Di Hao , Zhi-Qian Lin , Xiao-Yu Guo , Jiao Liang , Can-Kun Luo , Qian-Tao Wang , Li Guo , Yong Wu . Rhodium-catalyzed Doyle-Kirmse rearrangement reactions of sulfoxoniun ylides. Chinese Chemical Letters, 2024, 35(4): 108834-. doi: 10.1016/j.cclet.2023.108834
18. [18]
  Ruiying Liu , Li Zhao , Baishan Liu , Jiayuan Yu , Yujie Wang , Wanqiang Yu , Di Xin , Chaoqiong Fang , Xuchuan Jiang , Riming Hu , Hong Liu , Weijia Zhou . Modulating pollutant adsorption and peroxymonosulfate activation sites on Co3O4@N,O doped-carbon shell for boosting catalytic degradation activity. Chinese Journal of Structural Chemistry, 2024, 43(8): 100332-100332. doi: 10.1016/j.cjsc.2024.100332
19. [19]
  Botao QU , Qian WANG , Xiaogang NING , Yuxin ZHOU , Ruiping ZHANG . Deeply penetrating photoacoustic imaging in tumor tissues based on dual-targeted melanin nanoparticle. Chinese Journal of Inorganic Chemistry, 2024, 40(5): 1025-1032. doi: 10.11862/CJIC.20230416
20. [20]
  Wen Xiao , Fazhan Wang , Yangzhuo Gu , Xi He , Na Fan , Qian Zheng , Shugang Qin , Zhongshan He , Yuquan Wei , Xiangrong Song . PEG400-mediated nanocarriers improve the delivery and therapeutic efficiency of mRNA tumor vaccines. Chinese Chemical Letters, 2024, 35(5): 108755-. doi: 10.1016/j.cclet.2023.108755

Get Citation

PDF

XML

Metrics

PDF Downloads(4)
Abstract views(965)
HTML views(85)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142